MAPT and Alzheimer disease: In contrast, under AD conditions, the microglia switch to the neurotoxic (pro-inflammatory) phenotype during the advanced stage of AD, and pro-inflammatory cytokines also decrease the phagocytic activity of microglia, increase Aβ levels and exacerbate tau pathology, contributing to AD pathology 7, 8.